Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation

por Kono, K, Mimura, K, Kiessling, R
Publicado 2013

Fundamentals of energy dispersive X-ray analysis

por Russ, John C, Frs, M Ashby, Kiessling, R, Charles, J
Publicado 1984

“Anomalous” THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes

por Karre, K, Seeley, JK, Eriksson, E, Burton, RC, Kiessling, R
Publicado 1982

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer

por Miyan, M., Schmidt-Mende, J., Kiessling, R., Poschke, I., de Boniface, J.
Publicado 2016

Cripto-1 vaccination elicits protective immunity against metastatic melanoma

por Ligtenberg, M. A., Witt, K., Galvez-Cancino, F., Sette, A., Lundqvist, A., Lladser, A., Kiessling, R.
Publicado 2016

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker

por Salazar-Onfray, F, López, M, Lundqvist, A, Aguirre, A, Escobar, A, Serrano, A, Korenblit, C, Petersson, M, Chhajlani, V, Larsson, O, Kiessling, R
Publicado 2002

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

por Pavlenko, M, Roos, A-K, Lundqvist, A, Palmborg, A, Miller, A M, Ozenci, V, Bergman, B, Egevad, L, Hellström, M, Kiessling, R, Masucci, G, Wersäll, P, Nilsson, S, Pisa, P
Publicado 2004